Tonix Pharmaceuticals Holding Corp. (TNXP): Price and Financial Metrics
TNXP Price/Volume Stats
| Current price | $40.65 | 52-week high | $363.20 |
| Prev. close | $38.41 | 52-week low | $6.76 |
| Day low | $38.06 | Volume | 703,403 |
| Day high | $41.77 | Avg. volume | 1,386,643 |
| 50-day MA | $23.21 | Dividend yield | N/A |
| 200-day MA | $21.17 | Market Cap | 297.76M |
TNXP Stock Price Chart Interactive Chart >
Tonix Pharmaceuticals Holding Corp. (TNXP) Company Bio
Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company that develops therapies for disorders of the central nervous system ("CNS"). The Company develops therapies for disorders that include fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD").
TNXP Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TNXP Price Returns
| 1-mo | 112.38% |
| 3-mo | 212.21% |
| 6-mo | 121.53% |
| 1-year | -88.32% |
| 3-year | -99.91% |
| 5-year | -99.99% |
| YTD | 23.26% |
| 2024 | -97.44% |
| 2023 | -83.46% |
| 2022 | -96.59% |
| 2021 | -47.01% |
| 2020 | -42.31% |